Results 221 to 230 of about 111,076 (331)
Cancer Science, Volume 117, Issue 4, Page 917-928, April 2026.Cancer‐specific antihuman podoplanin antibody chLpMab‐2f exerted antibody‐dependent cellular cytotoxicity and complement‐dependent cytotoxicity against pleural mesothelioma (PM) cell lines. Additionally, chLpMab‐2f inhibited tumor progression in mice with subcutaneously and intrathoracically transplanted human PM cells.
Aito Yoshida +15 more
wiley +1 more source
Radioimmunotherapy for Malignant Mesothelioma Targeting C-ERC/Mesothelin. [PDF]
Pharmaceuticals (Basel)Hanaoka H +4 more
europepmc +1 more source
Synthesis and Biological Evaluation of NMDI14 Derivatives as Anti-Mesothelioma Agents
, 2020 Hiroshi Abe +5 more
openalex +1 more source
AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes
Clinical &Experimental Allergy, Volume 56, Issue 4, Page 344-368, April 2026.ABSTRACT The AllergoOncology field brings together the study of allergic and cancer immune responses, having evolved from early epidemiological studies that reported inverse associations between allergies, IgE and cancer risk. Insights from studying allergic inflammation are revealing previously unappreciated immune mechanisms that confer protective ...
Jakub Zydron +13 more
wiley +1 more source
From biology to therapy: current standards and emerging strategies in pleural mesothelioma. [PDF]
Front Oncolvan Genugten JHLT +2 more
europepmc +1 more source
Tumor suppressive Ca2+ signaling is driven by IP3 receptor fitness [PDF]
, 2017 Bultynck, G, Campanella, M
core +3 more sources
The emerging roles of BAP1 and cancer stem cells in Malignant Mesothelioma [PDF]
, 2019 Alice Guazzelli
openalex
RNA‐Sequencing Reveals Two Subgroups of Eccrine Porocarcinomas and Poromas
Journal of Cellular and Molecular Medicine, Volume 30, Issue 8, April 2026.ABSTRACT Eccrine porocarcinoma (EPC), a rare malignant eccrine gland tumour, remains molecularly understudied. Transcriptomic studies of EPC and benign eccrine poroma (EP) have identified recurrent fusions and expression changes, but differences distinguishing malignant EPC from benign EP are unclear.
Maya Puttonen +6 more
wiley +1 more source
Underutilization of CRS, HIPEC & PIPAC in peritoneal mesothelioma across a German nationwide cohort. [PDF]
World J Surg OncolMüller V +4 more
europepmc +1 more source
Malign Mesothelioma in Aegean Region (201 cases)
, 1996 Yrd.Doç.r. Oya Akpınar +5 more
openalex +1 more source